Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

Purdue researcher receives $2.4 million NIH grant to combat antimicrobial resistance in lung infections

Qi "Tony" Zhou, a researcher in Purdue University's College of Pharmacy has received a $2.4 million grant from the National Institutes of Health to fight lung infections that have established a resistance to antimicrobial drugs.

6 May 2024

Electric pulses boost gene therapy uptake in liver cells

In an effort to improve delivery of costly medical treatments, a team of researchers in electrical engineering at the University of Wisconsin–Madison has developed a stimulating method that could make the human body more receptive to certain gene therapies.

30 Apr 2024

RNA editing using CRISPRs shows promise for genetic disease treatment

A team at Montana State University published research this week that shows how RNA, the close chemical cousin to DNA, can be edited using CRISPRs.

29 Apr 2024

Hospital toilets harbor multi-drug resistant "superbugs", study finds

Pathogenic bacteria and fungi, including multi-drug resistant "superbugs" have been found on the floors, ceilings, door handles and other surfaces of hospital toilets in the UK, with patient toilets the worst affected, the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) will hear.

29 Apr 2024

Study reveals genetic divergence and drug resistance mechanisms in two critical superbugs

Infectious diseases caused by pathogenic strains of bacteria are a global cause of morbidity and mortality. Hospital-acquired infections caused by Klebsiella pneumonia and Pseudomonas aeruginosa were found vulnerable during the COVID-19 pandemic.

29 Apr 2024

Human mini-lungs mimic animal response to nanomaterials

Human mini-lungs grown by University of Manchester scientists can mimic the response of animals when exposed to certain nanomaterials.

27 Apr 2024

Study highlights how age affects nasal cell response to SARS-CoV-2

Researchers reveal age-related differences in nasal epithelial cell responses to SARS-CoV-2, showing variations in cell types and viral dynamics across pediatric, adult, and older adult groups.

16 Apr 2024

Cystic fibrosis drug found to be safe and effective in newborns

A Cystic Fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective in newborns aged four weeks and above, new research involving RCSI University of Medicine and Health Sciences and Children's Health Ireland has found.

12 Apr 2024

Understanding the mechanisms behind cystic fibrosis infections

Cystic fibrosis is a genetic disease that causes serious and sometimes fatal respiratory and digestive disorders.

4 Apr 2024

Researchers discover the lungs communicate directly with the brain to induce sickness symptoms

University of Calgary researchers have discovered the lungs communicate directly with the brain when there is an infection.

21 Mar 2024

New custom-designed proteins can efficiently reach intramembrane targets

Hitting targets embedded within the cell membrane has long been difficult for drug developers due to the membrane's challenging biochemical properties. Now, Scripps Research chemists have demonstrated new custom-designed proteins that can efficiently reach these "intramembrane" targets.

13 Mar 2024

Researchers take important step toward genetic therapy for hereditary conditions

Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss.

5 Mar 2024

UCSF scientists discover less invasive prenatal treatment for Angelman syndrome

In a discovery that opens the door to a less invasive way of treating some serious disorders before birth, UC San Francisco scientists have found that delivering medicine through amniotic fluid is as effective as delivering it to the fetal brain via cerebrospinal fluid.

4 Mar 2024

Penn engineers develop targeted lung delivery system using lipid nanoparticles

Penn Engineers have developed a new means of targeting the lungs with lipid nanoparticles (LNPs), the miniscule capsules used by the Moderna and Pfizer-BioNTech COVID-19 vaccines to deliver mRNA, opening the door to novel treatments for pulmonary diseases like cystic fibrosis.

1 Mar 2024

Breakthrough discovery offers hope for reducing infections in cystic fibrosis patients

University of Queensland researchers have identified an opportunity to reduce infections in people living with cystic fibrosis.

22 Feb 2024

Breakthrough gene therapy method utilizes bird retrotransposon for safe gene insertion

The recent approval of a CRISPR-Cas9 therapy for sickle cell disease demonstrates that gene editing tools can do a superb job knocking out genes to cure hereditary disease.

20 Feb 2024

Scientists coax a deadly bacterium to destroy itself from the inside out

Northwestern University researchers have successfully coaxed a deadly pathogen to destroy itself from the inside out.

31 Jan 2024

Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, today announced that it has closed a £26 million ($33.1 million USD) Series B follow-on financing round, led by Panakes Partners.

From Enterprise Therapeutics Ltd 31 Jan 2024

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

Researchers investigate the need for prioritizing COVID-19 booster vaccination.

19 Jan 2024

St. Jude scientists develop novel spectinomycin derivatives to combat Mycobacterium abscessus

Scientists at St. Jude Children's Research Hospital are tackling Mycobacterium abscessus (Mab) antibiotic resistance.

5 Jan 2024

Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

Purdue researcher receives $2.4 million NIH grant to combat antimicrobial resistance in lung infections

Electric pulses boost gene therapy uptake in liver cells

RNA editing using CRISPRs shows promise for genetic disease treatment

Hospital toilets harbor multi-drug resistant "superbugs", study finds

Study reveals genetic divergence and drug resistance mechanisms in two critical superbugs

Human mini-lungs mimic animal response to nanomaterials

Study highlights how age affects nasal cell response to SARS-CoV-2

Cystic fibrosis drug found to be safe and effective in newborns

Understanding the mechanisms behind cystic fibrosis infections

Researchers discover the lungs communicate directly with the brain to induce sickness symptoms

New custom-designed proteins can efficiently reach intramembrane targets

Researchers take important step toward genetic therapy for hereditary conditions

UCSF scientists discover less invasive prenatal treatment for Angelman syndrome

Penn engineers develop targeted lung delivery system using lipid nanoparticles

Breakthrough discovery offers hope for reducing infections in cystic fibrosis patients

Breakthrough gene therapy method utilizes bird retrotransposon for safe gene insertion

Scientists coax a deadly bacterium to destroy itself from the inside out

Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

St. Jude scientists develop novel spectinomycin derivatives to combat Mycobacterium abscessus

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Newsletters you may be interested in